How Israel is winning the Covid-19 vaccine race
More than 12% of population have already had jabs - but Palestinians in occupied territories excluded from rollout
As countries worldwide scramble to secure doses of the Pfizer and Oxford vaccines, Israel has taken a commanding lead in the race to protect its population from Covid-19.
More than a million Israelis have already been inoculated - a vaccination rate of 12.59 per 100 people, according to latest data from the University of Oxford. The Persian Gulf island nation of Bahrain is in second place with 3.57, with the UK in third on 1.39.
Israel began its vaccine rollout on 19 December and is “delivering jabs to about 150,000 people a day, with priority given to the over-60s, health workers and people who are clinically vulnerable”, the BBC reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Like their UK counterparts, the Israeli government secured a sizeable supply of the Pfizer vaccine after opening negotiations with the US-based pharmaceutical giant early in the pandemic. But the vaccination push in the Middle Eastern nation has also been aided by laws stipulating that “all Israelis must register with a recognised health care provider”, the broadcaster adds.
By 1 January, more than 10% of the population had received a Covid jab, with the “heavily digitised, community-based health system” and “centralised government” proving to be key assets in the mass vaccination campaign, says The New York Times.
The country’s embattled Prime Minister Benjamin Netanyahu was the first Israeli to receive the vaccine, in an effort to convince the public of its safety.
During a visit last week to a vaccination centre in the town of Tira, in central Israel, he said: “We brought millions of vaccines here, more than any other country in the world relative to its population. We brought them to everyone: Jews and Arabs, religious and secular. Come and be vaccinated.”
However, his government has come under fire from human rights groups for leaving Palestinians in the Israeli-occupied West Bank and Gaza to “watch and wait” as vaccines “are only distributed to Jewish settlers” in the disputed territories, The Guardian reports.
“The cash-strapped Palestinian Authority, which maintains limited self-rule in the territories, is rushing to get vaccines,” the paper adds. But Ali Abed Rabbo, director-general of the Palestinian health ministry, has estimated that the first vaccines will not arrive in the West Bank and Gaza Strip until February.
Israeli rights group Gisha told The Guardian that the bid by Palestinian authorities to procure their own supply of vaccines “does not absolve Israel from its ultimate responsibility toward Palestinians under occupation”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
6 charming homes for the whimsical
Feature Featuring a 1924 factory-turned-loft in San Francisco and a home with custom murals in Yucca Valley
By The Week Staff Published
-
Big tech's big pivot
Opinion How Silicon Valley's corporate titans learned to love Trump
By Theunis Bates Published
-
Stacy Horn's 6 favorite works that explore the spectrum of evil
Feature The author recommends works by Kazuo Ishiguro, Anthony Doerr, and more
By The Week US Published
-
Gaza ceasefire, hostage deal on track to start by Monday
Speed Read A deal between Israel and Hamas to release hostages and begin a ceasefire was officially signed by representatives in Doha
By Peter Weber, The Week US Published
-
Israel and Hamas reach long-awaited Gaza ceasefire
The Explainer After more than a year of violence that has left tens of thousands dead and pushed the Middle East toward broader regional war, negotiators say an end is in sight
By Rafi Schwartz, The Week US Published
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but it's too soon to succumb to defeatist gloom
By The Week UK Published
-
Romania's election rerun
The Explainer Shock result of presidential election has been annulled following allegations of Russian interference
By Sorcha Bradley, The Week UK Published
-
Russia's shadow war in Europe
Talking Point Steering clear of open conflict, Moscow is slowly ratcheting up the pressure on Nato rivals to see what it can get away with.
By The Week UK Published
-
Cutting cables: the war being waged under the sea
In the Spotlight Two undersea cables were cut in the Baltic sea, sparking concern for the global network
By The Week UK Published
-
The nuclear threat: is Vladimir Putin bluffing?
Talking Point Kremlin's newest ballistic missile has some worried for Nato nations
By The Week UK Published
-
Russia vows retaliation for Ukrainian missile strikes
Speed Read Ukraine's forces have been using U.S.-supplied, long-range ATCMS missiles to hit Russia
By Arion McNicoll, The Week UK Published